Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU Commission's SCENIHR casts fresh eye over PIP implant safety, MoM hips

This article was originally published in Clinica

Executive Summary

SCENIHR, the European Commission’s scientific committee that assesses emerging and newly identified health risks, is to give a second opinion in June on the safety of the controversial PIP silicone gel breast implants. The devices, which were filled with industrial-grade silicone and sold worldwide, became the centre of a public health storm at end of 2011 and threw the medtech industry - and the revision on the medical device directives - into turbulent waters last year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT099853

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel